Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cvrx Inc (CVRX)

Cvrx Inc (CVRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 160,766
  • Shares Outstanding, K 26,312
  • Annual Sales, $ 56,650 K
  • Annual Income, $ -53,310 K
  • EBIT $ -40 M
  • EBITDA $ -59 M
  • 60-Month Beta 1.31
  • Price/Sales 2.45
  • Price/Cash Flow N/A
  • Price/Book 3.23

Options Overview Details

View History
  • Implied Volatility 134.47% (+29.98%)
  • Historical Volatility 114.74%
  • IV Percentile 47%
  • IV Rank 13.84%
  • IV High 800.99% on 01/20/26
  • IV Low 27.44% on 09/02/25
  • Expected Move (DTE 27) 0.77 (12.52%)
  • Put/Call Vol Ratio 0.07
  • Today's Volume 47
  • Volume Avg (30-Day) 54
  • Put/Call OI Ratio 0.64
  • Today's Open Interest 2,587
  • Open Int (30-Day) 2,289
  • Expected Range 5.35 to 6.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.51
  • Number of Estimates 3
  • High Estimate -0.45
  • Low Estimate -0.56
  • Prior Year -0.53
  • Growth Rate Est. (year over year) +3.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.37 +39.81%
on 02/17/26
7.84 -22.07%
on 01/26/26
+0.52 (+9.30%)
since 01/20/26
3-Month
4.37 +39.81%
on 02/17/26
10.28 -40.56%
on 11/25/25
-2.69 (-30.57%)
since 11/20/25
52-Week
4.30 +42.12%
on 05/12/25
14.14 -56.79%
on 02/21/25
-7.90 (-56.39%)
since 02/20/25

Most Recent Stories

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX

NEW YORK , Feb. 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised to contact...

CVRX : 6.11 (+15.72%)
CVRx, Inc. (CVRX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith announces an investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX ) investors concerning the Company’s possible violations...

CVRX : 6.11 (+15.72%)
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz announces an investigation of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX ) on behalf of investors concerning the Company’s possible...

CVRX : 6.11 (+15.72%)
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”)...

CVRX : 6.11 (+15.72%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX

NEW YORK , Feb. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised to contact...

CVRX : 6.11 (+15.72%)
CVRx: Q4 Earnings Snapshot

CVRx: Q4 Earnings Snapshot

CVRX : 6.11 (+15.72%)
CVRx Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

MINNEAPOLIS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...

CVRX : 6.11 (+15.72%)
CVRX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving CVRx Inc.

The law firm of Kirby McInerney LLP continues its investigation on behalf of CVRx Inc. (“CVRx” or the “Company”) (NASDAQ:CVRX) investors concerning the Company’s and/or members...

CVRX : 6.11 (+15.72%)
CVRx INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

The law firm of Kirby McInerney LLP is investigating potential claims against CVRx Inc. (“CVRx” or the “Company”) (NASDAQ:CVRX). The investigation concerns whether the Company and/or...

CVRX : 6.11 (+15.72%)
CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026

MINNEAPOLIS, Jan. 29, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...

CVRX : 6.11 (+15.72%)

Business Summary

CVRx Inc. is a commercial-stage medical device company. It focused on developing, manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx Inc. is headquartered in Minneapolis, MN.

See More

Key Turning Points

3rd Resistance Point 7.92
2nd Resistance Point 7.20
1st Resistance Point 6.66
Last Price 6.11
1st Support Level 5.39
2nd Support Level 4.67
3rd Support Level 4.13

See More

52-Week High 14.14
Fibonacci 61.8% 10.38
Fibonacci 50% 9.22
Fibonacci 38.2% 8.06
Last Price 6.11
52-Week Low 4.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar